Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in pediatric NAFLD
NCT01913470Phase 2Completed
- Sponsor
- Miriam Vos
- Start
- Jul 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in non-alcoholic fatty liver disease (NAFLD), sponsored by Miriam Vos. Started Jul 2013; status: completed.
02
Drugs
losartan
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01913470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913470.